Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

441

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Type 2 Diabetes
Interventions
DRUG

Rivoglitazone

DRUG

Pioglitazone

DRUG

Placebo

Trial Locations (74)

Unknown

Birmingham

Columbiana

Huntsville

Muscle Shoals

Hot Springs

Jonesboro

Little Rock

Searcy

Sherwood

Los Angeles

Moreno Valley

Sacramento

San Diego

San Mateo

Santa Monica

Torrance

Vista

West Hills

Newark

Clearwater

Cocoa Beach

Jupiter

Largo

Miami

New Port Richey

Palm Harbor

Pembroke Pines

Tampa

West Palm Beach

Warner Robins

Chicago

Gurnee

Evansville

Lexington

New Orleans

Detroit

Livonia

Kansas City

St Louis

Bozeman

Butte

Great Falls

Voorhees Township

Rochester

Charlotte

Statesville

Winston-Salem

Cincinnati

Columbus

Marion

Clinton

Oklahoma City

Tulsa

Medford

Philadelphia

Pittsburgh

Charleston

Simpsonville

Bristol

Carrollton

Conroe

Houston

Midland

San Antonio

Spring

Sugar Land

Norfolk

Richmond

Virginia Beach

Lakewood

Olympia

Renton

Spokane

Milwaukee

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY